Welsh, Carson, Anderson & Stowe (WCAS)
PE
1979
$12 500 M
New York City, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
The Welsh Carson Way
Since 1979, WCAS has been partnering with outstanding management teams to build leading healthcare and technology companies. Our deep experience and unparalleled network of relationships help us find the best investment opportunities and help our portfolio companies grow.
Our Strategy
WCAS invests in growth-oriented companies in our two focus industries: healthcare and technology. Our strategy is to buy growth businesses, partner with outstanding management teams, and build value through a combination of operational improvements, internal growth initiatives and strategic acquisitions.
For four decades, we have been building our Firm and businesses the Welsh Carson Way. Relationships are the foundation for our success, and we build those relationships with integrity, honesty, and transparency.
For four decades, we have been building our Firm and businesses the Welsh Carson Way. Relationships are the foundation for our success, and we build those relationships with integrity, honesty, and transparency.
Industry
Region of investment
Welsh, Carson, Anderson & Stowe (WCAS) Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
WCAS XII, L.P
|
Venture Capital (VC)
|
Education
Financial Services
Fintech
Healthcare Services
Software
Technology
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$3200 M
|
December 2016
|
|
WCAS XIII, L.P
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$4300 M
|
December 2019
|
|
WCAS XIV, L.P
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$5000 M
|
July 2023
|
